Okla. Stat. tit. 63, § 63-1-1412: Advertisements - False or misleading

(a) An advertisement of a drug, device, or cosmetic shall be

deemed to be false if it is false or misleading in any particular.

(b) For the purposes of this article, the advertisement of a

drug or device representing it to have any effect in albuminuria,

appendicitis, arteriosclerosis, blood poison, bone disease, Bright's

disease, cancer, carbuncles, cholecystitis, diabetes, diphtheria,

dropsy, erysipelas, gallstone, heart and vascular diseases, high

blood pressure, mastoiditis, measles, meningitis, mumps, nephritis,

otitis media, paralysis, pneumonia, poliomyelitis (infantile

paralysis), prostate gland disorders, pyelitis, scarlet fever,

sexual impotence, sinus infection, smallpox, tuberculosis, tumors,

typhoid, uremia, or sexually transmitted infection (STI) shall also

be deemed to be false, except that no advertisement not in violation

of subsection (a) of this section shall be deemed to be false under

this subsection if it is disseminated only to members of the

medical, dental, or veterinary professions, or appears only in

scientific periodicals of those professions, or is disseminated only

for the purpose of public health education by persons not

commercially interested, directly or indirectly, in the sale of

drugs or devices; provided, that whenever the State Commissioner of

Health determines that an advance in medical science has made any

type of self-medication safe as to any of the diseases named above,

the State Board of Health shall by regulation authorize the

advertisement of drugs having curative or therapeutic effect for

such disease, subject to such conditions and restrictions as the

Board and the Commissioner may deem necessary in the interests of

public health; provided, that this subsection shall not be construed

as indicating that self-medication for disease other than those

named herein is safe or efficacious.